
{
  "symbol": "ALLO",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology sector is prone to speculation",
      "Small market capitalization",
      "Clinical stage company with no revenue"
    ],
    "riskScore": 8,
    "reason": "Allogene Therapeutics operates in the speculative biotech sector with a small market cap and is in clinical stages, making it susceptible to retail-driven volatility."
  }
}
